Bleomycin, vincristine, and methotrexate (BOM) in squamous cell carcinoma of the lung: A phase II study

A. Libretti, E. Piazza, A. Scanni, M. Tomirotti, M. Biraghi, R. Scapaticci, C. Bianchi, G. Restelli, G. Scarpazza, M. P. Calzavara, S. Marsoni, L. Morasca

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)171-172
Number of pages2
JournalCancer Treatment Reports
Volume65
Issue number1-2
Publication statusPublished - 1981

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Libretti, A., Piazza, E., Scanni, A., Tomirotti, M., Biraghi, M., Scapaticci, R., Bianchi, C., Restelli, G., Scarpazza, G., Calzavara, M. P., Marsoni, S., & Morasca, L. (1981). Bleomycin, vincristine, and methotrexate (BOM) in squamous cell carcinoma of the lung: A phase II study. Cancer Treatment Reports, 65(1-2), 171-172.